The U.S. Food and Drug Administration (FDA) has announced the launch of its Digital Health Center of Excellence, which will be within the Center for Devices and Radiological Health (CDRH).
The Center will aim to further the agency’s goal of advancing digital health technology, including mobile health devices, software as a medical device (SaMD), wearables used with medical devices, and technology to study medical products.
“Today’s announcement marks the next stage in applying a comprehensive approach to digital health technology to realize its full potential to empower consumers to make better-informed decisions about their own health and provide new options for facilitating prevention, early diagnosis of life-threatening diseases, and management of chronic conditions outside of traditional care settings. The Digital Health Center of Excellence will provide centralized expertise and serve as a resource for digital health technologies and policy for digital health innovators, the public, and FDA staff,” said FDA Commissioner Stephen M. Hahn, MD in a recent press release.
The agency will appoint Bakul Patel as the first director, who has been leading regulatory and scientific efforts related to digital health devices at the FDA since 2010.
For additional coverage from Medical Economics, read this article.
Study highlights need for interventions to prevent postpartum smoking relapse
January 21st 2025Smoking cessation during pregnancy not only reduces pregnancy complications but also lowers the risk of relapse and new smoking initiation in the first postpartum year, according to a recent study.
Read More
USPSTF recommends osteoporosis screening for senior women to prevent fractures
January 20th 2025The US Preventive Services Task Force emphasizes screening for osteoporosis in women aged 65 years and older and at-risk postmenopausal women aged under 65 years, citing moderate benefits in fracture prevention.
Read More